Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02947165 |
Title | Phase I/Ib Study of NIS793 in Combination With PDR001 in Patients With Advanced Malignancies. |
Recruitment | Completed |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Novartis Pharmaceuticals |
Indications | |
Therapies | |
Age Groups: | |
Covered Countries | USA | ITA | DEU | CHE | CAN | AUT |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Sarah Cannon Research Institute SC | Nashville | Tennessee | 37203 | United States | Details | |
Huntsman Cancer Institute SC | Salt Lake City | Utah | 84112 | United States | Details | |
Novartis Investigative Site | Salzburg | 5020 | Austria | Details | ||
Novartis Investigative Site | Toronto | Ontario | M5G 2C1 | Canada | Details | |
Novartis Investigative Site | Ulm | 89081 | Germany | Details | ||
Novartis Investigative Site | Wuerzburg | 97080 | Germany | Details | ||
Novartis Investigative Site | Hong Kong | Hong Kong | Details | |||
Novartis Investigative Site | Milano | MI | 20132 | Italy | Details | |
Novartis Investigative Site | Rozzano | MI | 20089 | Italy | Details | |
Novartis Investigative Site | Kashiwa | Chiba | 277 8577 | Japan | Details | |
Novartis Investigative Site | St. Gallen | 9007 | Switzerland | Details | ||
Novartis Investigative Site | Taipei | 10002 | Taiwan | Details |